Clear Cell Renal Cell Carcinoma

CLINICAL_TRIALS trial_result · 2017-10-10

Clinical Trial Update: Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors [Phase 1]

Phase 1 trial of sunitinib malate in adults with unresectable or metastatic kidney cancer and other advanced solid tumors. The study status …

CLINICAL_TRIALS trial_result · 2017-08-23

Clinical Trial Update: First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma [Phase 4]

A Phase 4 clinical trial update reports completion of a study evaluating first-line pazopanib in poor-risk patients with metastatic renal ce…

CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors [Phase 2]

Phase 2 clinical trial evaluating combination chemotherapy, radiation therapy, and/or surgery for high-risk pediatric kidney tumors; results…

CLINICAL_TRIALS trial_result · 2017-06-08

Clinical Trial Update: Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer [NA]

A terminated clinical trial used dynamic contrast-enhanced MRI to measure the effects of pazopanib in metastatic kidney cancer, with results…

CLINICAL_TRIALS trial_result · 2017-05-24

Clinical Trial Update: BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma [Phase 1, Phase 2]

Clinical trial update for BNC105P combined with everolimus in progressive metastatic clear cell renal cell carcinoma; phases 1 and 2 complet…

CLINICAL_TRIALS trial_result · 2017-05-17

Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate [Phase 1, Phase 2]

Phase 1/2 trial investigating panobinostat and everolimus in metastatic or unresectable renal cell cancer after failure of sunitinib or sora…

CLINICAL_TRIALS other · 2017-03-15

Clinical Trial Update: Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer [Phase 1]

A Phase 1 trial combining stereotactic body radiation therapy with T-cell infusion for metastatic renal cell carcinoma has been terminated.

CLINICAL_TRIALS trial_result · 2017-03-10

Clinical Trial Update: A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy [Phase 2]

Phase 2 trial evaluating RO4929097 in patients with advanced renal cell carcinoma after VEGF/VEGFR therapy has completed with results posted…

CLINICAL_TRIALS trial_result · 2017-03-07

Clinical Trial Update: Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project [Phase 1]

Phase 1 COLPAN trial evaluating near-infrared technology to assist laparoscopic resection of pancreatic lesions has completed, including pan…

CLINICAL_TRIALS trial_result · 2017-02-24

Clinical Trial Update: Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA [Phase 2]

Phase 2 trial assessing safety and activity of G-202 in PSMA-expressing clear cell renal cell carcinoma completed.

CLINICAL_TRIALS trial_result · 2017-02-20

Clinical Trial Update: Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma [Phase 1]

Phase 1 trial evaluating the combination of Interleukin-2 with sorafenib for unresectable or metastatic clear cell renal cell carcinoma and …

CLINICAL_TRIALS trial_result · 2016-12-12

Clinical Trial Update: Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery [Phase 3]

Phase 3 trial evaluating sunitinib malate or sorafenib tosylate for kidney cancer post-surgery has completed; results posted.

CLINICAL_TRIALS trial_result · 2016-11-08

Clinical Trial Update: Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL) [Phase 1, Phase 2]

This document describes an early-phase dose-finding and safety/efficacy study of radium-223 dichloride (Xofigo) in patients with clear-cell …

CLINICAL_TRIALS trial_result · 2016-09-16

Clinical Trial Update: Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer [Phase 2]

Phase 2 trial evaluating sorafenib with or without recombinant interferon alfa-2b in patients with metastatic renal cell carcinoma; results …

CLINICAL_TRIALS trial_result · 2016-08-19

Clinical Trial Update: Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus [Phase 2]

This Phase 2 trial examined biomarkers before and after nephrectomy in patients with locally advanced or metastatic renal cell carcinoma tre…

CLINICAL_TRIALS trial_result · 2016-07-28

Clinical Trial Update: Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

A completed study validating a predictive nomogram for response or resistance to targeted therapies in metastatic clear cell renal cell carc…

CLINICAL_TRIALS trial_result · 2016-03-25

Clinical Trial Update: AMG 172 First in Human Study in Patients With Kidney Cancer [Phase 1]

A first-in-human Phase 1 trial of AMG 172 in patients with kidney cancer has completed.

CLINICAL_TRIALS withdrawal · 2016-03-03

Clinical Trial Update: A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer [NA]

This clinical trial (NCT02307474) evaluating SBRT with adjuvant pazopanib for renal cell carcinoma has been withdrawn.

CLINICAL_TRIALS research · 2016-02-25

Clinical Trial Update: A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment [NA]

A clinical trial investigating a CpG-methylation-based assay to stratify stage III clear cell renal cell carcinoma patients for adjuvant tre…

CLINICAL_TRIALS trial_result · 2015-09-09

Clinical Trial Update: Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 1, Phase 2]

Phase 1/2 trial evaluating vorinostat in combination with bevacizumab for unresectable or metastatic renal cell carcinoma has completed with…

CLINICAL_TRIALS trial_result · 2015-08-13

Clinical Trial Update: Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer [Phase 2]

Phase II study of Lutetium-177 labeled girentuximab for metastatic clear cell renal cell carcinoma has completed.

CLINICAL_TRIALS trial_result · 2015-05-05

Clinical Trial Update: Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer [Phase 2]

Phase 2 trial investigating bevacizumab, sorafenib tosylate, and temsirolimus in metastatic kidney cancer has completed with posted results.

CLINICAL_TRIALS research · 2015-03-05

Clinical Trial Update: Value of Various Chemokines in the Detection and Follow up of RCC

A clinical trial update evaluating the value of various chemokines for detecting and monitoring clear cell renal cell carcinoma.

CLINICAL_TRIALS trial_result · 2015-02-04

Clinical Trial Update: Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer [Phase 2]

Phase 2 trial update for Tandutinib in patients who had surgery for metastatic renal cell carcinoma, including clear cell and recurrent dise…

CLINICAL_TRIALS trial_result · 2015-02-03

Clinical Trial Update: 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC [Phase 2]

This Phase 2 trial assesses dovitinib as a first-line treatment for clear cell renal cell carcinoma. It also analyzes correlations between g…

Top drugs studied for this disease